Off-label prescriptions, side effects, and lawsuits: Navigating ethical and legal dilemmas
A recent TV advertisement attempted to recruit clients for a class action suit against a pharmaceutical manufacturer (PM) for a medication side effect (SE). The “cause of action” was unstated: was it the side effect’s existence or that the company failed to emphasize its severity? The SE was acknowledged not only by the company but
Read more…
Off-label prescriptions, side effects, and lawsuits: Navigating ethical and legal dilemmas originally appeared in KevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - March 23, 2024 Category: General Medicine Authors: M. Bennet Broner, PhD Tags: Meds Medications Source Type: blogs
Mental Illness, Health Care, and Assisted Death: Examining Parameters for Expanding or Restricting MAID Under Canada's Charter and Federal System
Mary J. Shariff (University of Manitoba), Derek Ross (Christian Legal Fellowship), Trudo Lemmens (University of Toronto), Mental Illness, Health Care, and Assisted Death: Examining Parameters for Expanding or Restricting MAID Under Canada ' s Charter and Federal System, Man. L. Rev. (2024):... (Source: HealthLawProf Blog)
Source: HealthLawProf Blog - March 23, 2024 Category: Medical Law Authors: Katharine Van Tassel Source Type: blogs
University of Houston Law Center and Fertitta Family College of Medicine Presents Justice and Health For All: The Future of Affirmative Action in Legal and Medical Education
; 8:30AM – 4:30PM on Friday, April 12th, 2024. This activity has been planned... (Source: HealthLawProf Blog)
Source: HealthLawProf Blog - March 22, 2024 Category: Medical Law Authors: Katharine Van Tassel Source Type: blogs
Endava to Acquire GalaxE Solutions to Boost Its Position in North America Healthcare With Delivery from India
Endava, a leading technology services company combining world-class engineering, industry expertise, and a people-centric mindset, has entered into a definitive agreement to acquire 100% ownership of GalaxE Group, Inc. (GalaxE), a global IT and business solutions provider headquartered in New Jersey, United States.
Founded by Tim Bryan over 30 years ago, GalaxE has been singularly focused on driving digital transformation for Fortune 500 companies in the healthcare, financial services, and retail industries.
When completed, the transaction will add approximately 1,650 employees and provide several key strategic benefits to...
Source: EMR and HIPAA - March 21, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Akin Gump Strauss Hauer & Feld LLP BofA Securities Endava GalaxE GalaxE Group Inc. Health IT Acquisitions Healthcare M&A John Cotterell JP Morgan Securities LLC Tim Bryan White & Case LLP Source Type: blogs
The Risks and Concerns of Ambient Clinical Voice Technology
Before integrating a new technology into your organization, it’s important that you’ve thought through all of the potential risks and concerns that can come with that technology. So while there are a lot of benefits to come from ambient clinical voice technology, we have to be sure that we are prepared for the challenges. As it is only through being prepared that we can prevent these risks.
So what are the risks and concerns of ambient clinical voice technology and how could they be holding people back from adopting it? In search of an answer to this question, we reached out to our insightful Healthcare IT Toda...
Source: EMR and HIPAA - March 20, 2024 Category: Information Technology Authors: Grayson Miller Tags: AI/Machine Learning Ambulatory Clinical EMR-EHR Health IT Company Healthcare IT Hospital - Health System LTPAC Security and Privacy 3M Health Information Systems ACV AI Hallucination Ambient Clinical Voice Anish Patankar Detlef Source Type: blogs
Disability Activist: Take Great Care When Seeing Bias Toward Disabled Citizens
By RANDY SOUDERS
During the years I served as Chairman of the Board for Jean Kennedy Smith’s Arts and Disability program, Very Special Arts (VSA at the Kennedy Center), I had there opportunity to meet a wide range of remarkable and courageous disabled Americans. Among the lasting friendships is a painter and visual artist, Randy Souders, who was rendered quadriplegic at the age of 17 in a 1972 accident. His concerns of late have been heightened by Trump and MAGA Republicans. I share his communication with his permission here in the hope that tech designers and others will be alert to the fact that great care is requir...
Source: The Health Care Blog - March 20, 2024 Category: Consumer Health News Authors: matthew holt Tags: Health Policy Disability eugenics Holocaust Mike Magee Randy Souders Trump Source Type: blogs
Opioid prescribing, pain management, and patient advocacy [PODCAST]
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! We delve into the complexities of opioid prescribing, pain management, and the opioid crisis with our guest, Richard A. Lawhern. As a patient advocate, Richard brings a unique perspective to the table. Join us as we discuss the discrepancies in data
Read more…
Opioid prescribing, pain management, and patient advocacy [PODCAST] originally appeared in KevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - March 19, 2024 Category: General Medicine Authors: The Podcast by KevinMD Tags: Podcast Pain Management Source Type: blogs
Assisted suicide: Safeguards debated as bioethicist warns of unintended consequences
At a time when many states are considering assisted suicide legislation, I was interested to encounter the perspective of the well-known bioethicist Arthur Caplan who recently expressed his support for these laws on these pages. While I appreciate Caplan’s endorsement of protecting doctors’ ability to refuse, as a matter of conscience, to participate in assisted death, I
Read more…
Assisted suicide: Safeguards debated as bioethicist warns of unintended consequences originally appeared in KevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - March 19, 2024 Category: General Medicine Authors: Philip Reed Tags: Conditions Palliative Care Source Type: blogs
Disability and the Ongoing Federalism Revolution
Katie R. Eyer (Rutgers University), Karen Tani (University of Pennsylvania), Disability and the Ongoing Federalism Revolution, 133 Yale L.J. (2024): The Supreme Court ’s “new federalism” revolution remains one of the most important developments in recent U.S. legal history. The Court... (Source: HealthLawProf Blog)
Source: HealthLawProf Blog - March 19, 2024 Category: Medical Law Authors: Katharine Van Tassel Source Type: blogs
Non-competes: Legal updates that give physicians options [PODCAST]
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! Did you know that non-compete contracts in the health care industry are constantly evolving? Join family physician and entrepreneur Tod Stillson as we dive into the latest legal changes impacting physicians’ professional mobility. In this episode, we explore how these reforms
Read more…
Non-competes: Legal updates that give physicians options [PODCAST] originally appeared in KevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - March 18, 2024 Category: General Medicine Authors: The Podcast by KevinMD Tags: Podcast Practice Management Source Type: blogs
The Discursive Contributions of Debates on Intellectual Property and Human Rights
Peter K. Yu (Texas A&M University), The Discursive Contributions of Debates on Intellectual Property and Human Rights (Texas A&M U. Sch. of L. Legal Stud. Rsch. Paper No. 24-12) (2024): In April 2020, a month after the World Health Organization... (Source: HealthLawProf Blog)
Source: HealthLawProf Blog - March 18, 2024 Category: Medical Law Authors: Katharine Van Tassel Source Type: blogs
Medicare Drug Pricing Negotiations: Assessing Constitutional Structural Limits
Erica N. White (Arizona State University), Mary Saxon (Arizona State University), James G. Hodge (Arizona State University), Joel Michaels (Arizona State University), Medicare Drug Pricing Negotiations: Assessing Constitutional Structural Limits (Ariz. St. U. Sandra Day O ’Conner Coll. of L. Legal... (Source: HealthLawProf Blog)
Source: HealthLawProf Blog - March 18, 2024 Category: Medical Law Authors: Katharine Van Tassel Source Type: blogs
Will Americans Get PBM Reform in 2024? Maybe, But Many Things Need to Happen I Order to Get There. On the Upside: Insulin Has Opted Out of PBM Sales.
At the core of this post is a YouTube video which can be viewed in the middle of this blog post. The subject is about whether we ' ll get much-needed legislation passed into law to reform corrupt Pharmacy Benefit Managers (PBMs) which we know with absolute certainty were at fault for runaway insulin prices. At least that was true until March 2023, when the three largest insulin manufacturers, starting withLilly, followed byNovo Nordisk and shortly thereafter,Sanofi all announced major insulin list price reductions in the range of 70% to 78%. Think about that for a second: Imagine being able to instantly...
Source: Scott's Web Log - March 17, 2024 Category: Endocrinology Tags: 2024 Congress insulin prices PBM rebates reform Source Type: blogs
Will Americans Get PBM Reform in 2024? Maybe, But Many Things Need to Happen In Order to Get There. On the Upside: Insulin Has Opted Out of PBM Sales.
At the core of this post is a YouTube video which can be viewed in the middle of this blog post. The subject is about whether we ' ll get much-needed legislation passed into law to reform corrupt Pharmacy Benefit Managers (PBMs) which we know with absolute certainty were at fault for runaway insulin prices. At least that was true until March 2023, when the three largest insulin manufacturers, starting withLilly, followed byNovo Nordisk and shortly thereafter,Sanofi all announced major insulin list price reductions in the range of 70% to 78%. Think about that for a second: Imagine being able to instantly...
Source: Scott's Web Log - March 17, 2024 Category: Endocrinology Tags: 2024 Congress insulin prices PBM rebates reform Source Type: blogs
Rethinking the legal test for excessive pricing: Insights from the Landmark UK CMA v Pfizer/Flynn Case and Its Legal Implications
Miroslava Marinova (University of East London), Rethinking the legal test for excessive pricing: Insights from the Landmark UK CMA v Pfizer/Flynn Case and Its Legal Implications (2023): The legal treatment of excessive pricing in the pharmaceutical sector has been a... (Source: HealthLawProf Blog)
Source: HealthLawProf Blog - March 17, 2024 Category: Medical Law Authors: Katharine Van Tassel Source Type: blogs
